ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Response Genetics Inc (CE)

Response Genetics Inc (CE) (RGDXQ)

0,000001
0,00
(0,00%)
Geschlossen 13 Januar 10:00PM

Professionelle Tools für Privatanleger.

Wichtige Statistiken und Details

Current Price
0,000001
Gebot
0,00
Fragen
0,00
Volumen
-
0,00 Tagesbereich 0,00
0,000001 52-Wochen-Bereich 0,000001
Handelsende
0,000001
Handelsbeginn
-
Letzte Trade
Letzter Handelszeitpunkt
Durchschnittliches Volumen (3 Mio.)
15.750
Finanzvolumen
-
VWAP
-

RGDXQ Neueste Nachrichten

Great Basin Welcomes Kirk Calhoun to Board of Directors

Great Basin Welcomes Kirk Calhoun to Board of Directors Mr. Calhoun Will Serve as Head of the Audit Committee PR Newswire SALT LAKE CITY, June 2, 2015 SALT LAKE CITY, June 2, 2015 /PRNewswire/...

Response Genetics, Inc. Announces First Quarter 2015 Financial Results

LOS ANGELES, May 14, 2015 (GLOBE NEWSWIRE) -- Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests that help determine a patient's...

Response Genetics, Inc. to Release First Quarter 2015 Financial Results and Host Conference Call on May 14, 2015

LOS ANGELES, May 7, 2015 (GLOBE NEWSWIRE) -- Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests that help determine a patient's...

Response Genetics, Inc. Announces Fourth Quarter and Year-End 2014 Financial Results

LOS ANGELES, March 31, 2015 (GLOBE NEWSWIRE) -- Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests that help determine a patient's...

Response Genetics, Inc. to Release Fourth Quarter and Year-End 2014 Financial Results and Host Conference Call on March 31, 2...

LOS ANGELES, March 19, 2015 (GLOBE NEWSWIRE) -- Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests that help determine a patient's...

Response Genetics, Inc. Announces Presentations at the American Society of Clinical Oncology's Gastrointestinal Cancers Sympo...

LOS ANGELES, Jan. 15, 2015 (GLOBE NEWSWIRE) -- Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests that help determine a patient's...

Response Genetics Secures New York State Department of Health Approval for the Company's ResponseDX(R) Testing Services

LOS ANGELES, Dec. 11, 2014 (GLOBE NEWSWIRE) -- Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests that help determine a patient's...

Response Genetics Launches New Test for Cancer Immunotherapy Drug Development

LOS ANGELES, June 16, 2014 (GLOBE NEWSWIRE) -- Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests that help guide cancer therapy...

FDA-Cleared, Medicare-Reimbursed, ResponseDX: Tissue of Origin(TM) Test Added to National Institute of Health's (NIH) Genetic...

LOS ANGELES, June 12, 2014 (GLOBE NEWSWIRE) -- Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests that help guide cancer therapy...

Response Genetics Expands Distribution of ResponseDX(R) Product Portfolio Into International Markets

LOS ANGELES, May 14, 2014 (GLOBE NEWSWIRE) -- Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests that help guide cancer therapy...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10000000CS
4001.0E-61.0E-61.0E-6300001.0E-6CS
12001.0E-61.0E-61.0E-6157501.0E-6CS
26001.0E-61.0E-61.0E-678751.0E-6CS
52001.0E-61.0E-61.0E-645001.0E-6CS
156-9.9E-5-990.00010.00011.0E-662413.18E-6CS
260-0.002199-99.95454545450.00220.04461.0E-61192810.00588604CS

RGDXQ - Frequently Asked Questions (FAQ)

What is the current Response Genetics (CE) share price?
The current share price of Response Genetics (CE) is US$ 0,000001
What is the 1 year trading range for Response Genetics (CE) share price?
Response Genetics (CE) has traded in the range of US$ 0,000001 to US$ 0,000001 during the past year
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
CRGPCalissio Resources Group Inc (CE)
US$ 0,0004
(39.900,00%)
20k
SMMESmartMetric Inc (PK)
US$ 0,0001
(9.900,00%)
1,25M
NEOMNeoMedia Technologies Inc (CE)
US$ 0,0001
(9.900,00%)
534,97k
RRGIReality Racing Inc (CE)
US$ 0,0001
(9.900,00%)
209k
ELIQQElectriq Power Holdings Inc (CE)
US$ 0,0001
(9.900,00%)
290
IBKKFImining Technologies Inc (CE)
US$ 0,000001
(-100,00%)
100
EGIOQEdgio Inc (CE)
US$ 0,000001
(-99,99%)
905
CYBFCyberfort Software Inc (CE)
US$ 0,000001
(-99,88%)
20k
CHMJDWaverunner Capital Inc
 0,0045
(-99,40%)
106
CCTLCoin Citadel (PK)
US$ 0,000001
(-99,00%)
108k
HMBLHUMBL Inc (PK)
US$ 0,0009
(0,00%)
359,72M
GRLFGreen Leaf Innovations Inc (PK)
US$ 0,00015
(50,00%)
194,9M
AITXArtificial Intelligence Technology Solutions Inc (PK)
US$ 0,00375
(-1,32%)
188,36M
TSOITherapeutic Solutions International Inc (PK)
US$ 0,0002
(-33,33%)
168,26M
PHILPHI Group Inc (PK)
US$ 0,00025
(-16,67%)
129,87M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock